HK Stock MarketDetailed Quotes

01093 CSPC PHARMA

Watchlist
  • 5.180
  • +0.060+1.17%
Market Closed Nov 19 16:08 CST
60.58BMarket Cap10.59P/E (TTM)

CSPC PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Turnover
-4.94%22.69B
1.27%16.28B
11.54%8.98B
1.66%31.45B
1.57%23.87B
3.01%16.08B
2.28%8.05B
11.02%30.94B
13.83%23.5B
12.93%15.61B
Operating income
-4.94%22.69B
1.27%16.28B
11.54%8.98B
1.66%31.45B
1.57%23.87B
3.01%16.08B
2.28%8.05B
11.02%30.94B
13.83%23.5B
12.93%15.61B
Cost of sales
5.26%-6.7B
4.40%-4.63B
1.87%-2.49B
-6.83%-9.27B
-10.29%-7.07B
-13.37%-4.84B
-22.87%-2.53B
-28.95%-8.68B
-28.62%-6.41B
-29.53%-4.27B
Operating expenses
5.26%-6.7B
4.40%-4.63B
1.87%-2.49B
-6.83%-9.27B
-10.29%-7.07B
-13.37%-4.84B
-22.87%-2.53B
-28.95%-8.68B
-28.62%-6.41B
-29.53%-4.27B
Gross profit
-4.80%15.99B
3.71%11.65B
17.70%6.5B
-0.36%22.18B
-1.70%16.79B
-0.89%11.24B
-5.03%5.52B
5.31%22.26B
9.11%17.08B
7.73%11.34B
Selling expenses
5.79%-6.62B
2.55%-4.78B
-18.97%-2.96B
11.58%-9.14B
13.34%-7.03B
9.39%-4.9B
11.91%-2.49B
1.01%-10.34B
-4.32%-8.11B
-1.69%-5.41B
Administrative expenses
-2.88%-880.65M
-18.15%-632.84M
-26.51%-332.83M
-1.43%-1.19B
2.08%-855.97M
5.17%-535.64M
-1.07%-263.08M
-16.14%-1.17B
-16.82%-874.16M
-13.64%-564.82M
Research and development expenses
-5.49%-3.88B
-10.35%-2.54B
-16.04%-1.17B
-21.17%-4.83B
-25.95%-3.68B
-22.27%-2.3B
-11.77%-1.01B
-16.14%-3.99B
-16.43%-2.92B
-16.81%-1.88B
Special items of operating profit
-36.05%259.57M
-19.70%172.47M
41.09%59.06M
-48.38%420.59M
-8.36%405.88M
-13.72%214.78M
164.60%41.86M
49.32%814.85M
-22.03%442.91M
-54.52%248.93M
Operating profit
-13.72%4.86B
4.42%3.87B
16.13%2.09B
-1.82%7.44B
0.27%5.63B
-0.47%3.71B
2.37%1.8B
11.47%7.57B
8.24%5.62B
2.38%3.73B
Financing cost
-97.26%-33.29M
-104.95%-21.98M
-37.84%-6.11M
-4.04%-25.9M
-12.51%-16.88M
-10.29%-10.72M
-54.97%-4.43M
-224.78%-24.89M
-132.70%-15M
-103.22%-9.72M
Share of profits of associates
-19.90%-39.53M
-67.65%-27.24M
-24.61%-15.01M
3.40%-41.07M
29.06%-32.97M
39.72%-16.25M
-42.31%-12.05M
-77.91%-42.51M
-119.94%-46.48M
-38.43%-26.95M
Share of profit from joint venture company
-653.04%-41.44M
-983.37%-24.43M
-187.38%-13.48M
-148.43%-13.13M
-113.24%-5.5M
-108.12%-2.26M
-131.76%-4.69M
-41.49%27.11M
15.51%41.56M
32.14%27.78M
Special items of earning before tax
----
----
----
-31.63%32.86M
--32.86M
----
----
28.64%48.07M
----
----
Earning before tax
-15.41%4.75B
3.25%3.8B
15.57%2.06B
-2.54%7.39B
0.23%5.61B
-1.02%3.68B
0.97%1.78B
10.74%7.58B
7.18%5.6B
1.54%3.72B
Tax
2.28%-942.7M
-20.23%-749.66M
-37.35%-428.35M
2.48%-1.32B
5.98%-964.74M
9.95%-623.51M
5.39%-311.86M
-16.50%-1.35B
-24.40%-1.03B
-25.03%-692.38M
After-tax profit from continuing operations
-18.13%3.8B
-0.21%3.05B
10.94%1.63B
-2.56%6.07B
1.62%4.65B
1.02%3.06B
2.43%1.47B
9.56%6.23B
3.95%4.57B
-2.64%3.03B
Earning after tax
-18.13%3.8B
-0.21%3.05B
10.94%1.63B
-2.56%6.07B
1.62%4.65B
1.02%3.06B
2.43%1.47B
9.56%6.23B
3.95%4.57B
-2.64%3.03B
Minority profit
-83.53%24.77M
-65.85%31.09M
-57.68%17.04M
41.74%199.37M
45.84%150.38M
49.57%91.05M
35.22%40.26M
69.59%140.66M
66.96%103.11M
30.80%60.88M
Profit attributable to shareholders
-15.94%3.78B
1.80%3.02B
12.88%1.61B
-3.58%5.87B
0.60%4.49B
0.03%2.97B
1.73%1.43B
8.67%6.09B
3.06%4.47B
-3.15%2.97B
Basic earnings per share
-15.35%0.3203
2.24%0.2551
13.51%0.1361
-3.21%0.4947
0.93%0.3784
0.24%0.2495
1.70%0.1199
9.00%0.5111
3.39%0.3749
-2.85%0.2489
Diluted earnings per share
-15.33%0.3203
2.24%0.2551
13.51%0.1361
-3.21%0.4947
0.91%0.3783
0.24%0.2495
1.70%0.1199
9.00%0.5111
3.39%0.3749
-2.85%0.2489
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
Auditor
--
--
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
--
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Turnover -4.94%22.69B1.27%16.28B11.54%8.98B1.66%31.45B1.57%23.87B3.01%16.08B2.28%8.05B11.02%30.94B13.83%23.5B12.93%15.61B
Operating income -4.94%22.69B1.27%16.28B11.54%8.98B1.66%31.45B1.57%23.87B3.01%16.08B2.28%8.05B11.02%30.94B13.83%23.5B12.93%15.61B
Cost of sales 5.26%-6.7B4.40%-4.63B1.87%-2.49B-6.83%-9.27B-10.29%-7.07B-13.37%-4.84B-22.87%-2.53B-28.95%-8.68B-28.62%-6.41B-29.53%-4.27B
Operating expenses 5.26%-6.7B4.40%-4.63B1.87%-2.49B-6.83%-9.27B-10.29%-7.07B-13.37%-4.84B-22.87%-2.53B-28.95%-8.68B-28.62%-6.41B-29.53%-4.27B
Gross profit -4.80%15.99B3.71%11.65B17.70%6.5B-0.36%22.18B-1.70%16.79B-0.89%11.24B-5.03%5.52B5.31%22.26B9.11%17.08B7.73%11.34B
Selling expenses 5.79%-6.62B2.55%-4.78B-18.97%-2.96B11.58%-9.14B13.34%-7.03B9.39%-4.9B11.91%-2.49B1.01%-10.34B-4.32%-8.11B-1.69%-5.41B
Administrative expenses -2.88%-880.65M-18.15%-632.84M-26.51%-332.83M-1.43%-1.19B2.08%-855.97M5.17%-535.64M-1.07%-263.08M-16.14%-1.17B-16.82%-874.16M-13.64%-564.82M
Research and development expenses -5.49%-3.88B-10.35%-2.54B-16.04%-1.17B-21.17%-4.83B-25.95%-3.68B-22.27%-2.3B-11.77%-1.01B-16.14%-3.99B-16.43%-2.92B-16.81%-1.88B
Special items of operating profit -36.05%259.57M-19.70%172.47M41.09%59.06M-48.38%420.59M-8.36%405.88M-13.72%214.78M164.60%41.86M49.32%814.85M-22.03%442.91M-54.52%248.93M
Operating profit -13.72%4.86B4.42%3.87B16.13%2.09B-1.82%7.44B0.27%5.63B-0.47%3.71B2.37%1.8B11.47%7.57B8.24%5.62B2.38%3.73B
Financing cost -97.26%-33.29M-104.95%-21.98M-37.84%-6.11M-4.04%-25.9M-12.51%-16.88M-10.29%-10.72M-54.97%-4.43M-224.78%-24.89M-132.70%-15M-103.22%-9.72M
Share of profits of associates -19.90%-39.53M-67.65%-27.24M-24.61%-15.01M3.40%-41.07M29.06%-32.97M39.72%-16.25M-42.31%-12.05M-77.91%-42.51M-119.94%-46.48M-38.43%-26.95M
Share of profit from joint venture company -653.04%-41.44M-983.37%-24.43M-187.38%-13.48M-148.43%-13.13M-113.24%-5.5M-108.12%-2.26M-131.76%-4.69M-41.49%27.11M15.51%41.56M32.14%27.78M
Special items of earning before tax -------------31.63%32.86M--32.86M--------28.64%48.07M--------
Earning before tax -15.41%4.75B3.25%3.8B15.57%2.06B-2.54%7.39B0.23%5.61B-1.02%3.68B0.97%1.78B10.74%7.58B7.18%5.6B1.54%3.72B
Tax 2.28%-942.7M-20.23%-749.66M-37.35%-428.35M2.48%-1.32B5.98%-964.74M9.95%-623.51M5.39%-311.86M-16.50%-1.35B-24.40%-1.03B-25.03%-692.38M
After-tax profit from continuing operations -18.13%3.8B-0.21%3.05B10.94%1.63B-2.56%6.07B1.62%4.65B1.02%3.06B2.43%1.47B9.56%6.23B3.95%4.57B-2.64%3.03B
Earning after tax -18.13%3.8B-0.21%3.05B10.94%1.63B-2.56%6.07B1.62%4.65B1.02%3.06B2.43%1.47B9.56%6.23B3.95%4.57B-2.64%3.03B
Minority profit -83.53%24.77M-65.85%31.09M-57.68%17.04M41.74%199.37M45.84%150.38M49.57%91.05M35.22%40.26M69.59%140.66M66.96%103.11M30.80%60.88M
Profit attributable to shareholders -15.94%3.78B1.80%3.02B12.88%1.61B-3.58%5.87B0.60%4.49B0.03%2.97B1.73%1.43B8.67%6.09B3.06%4.47B-3.15%2.97B
Basic earnings per share -15.35%0.32032.24%0.255113.51%0.1361-3.21%0.49470.93%0.37840.24%0.24951.70%0.11999.00%0.51113.39%0.3749-2.85%0.2489
Diluted earnings per share -15.33%0.32032.24%0.255113.51%0.1361-3.21%0.49470.91%0.37830.24%0.24951.70%0.11999.00%0.51113.39%0.3749-2.85%0.2489
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions ------Unqualified Opinion------Unqualified Opinion----
Auditor ------Deloitte Guan Huang Chen Fang Certified Public Accountants------Deloitte Guan Huang Chen Fang Certified Public Accountants----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data